


Embera NeuroTherapeutics Completes Series B Financing and Receives Grants to Advance EMB-001 into Phase 2 Clinical Studies in Cocaine Use Disorder and Smoking Cessation
Novel addiction treatment discovered in Shreveport, La. advances into Phase 2 clinical studies for cocaine use disorder and smoking cessation BRF New Louisiana Angel Fund (NLAF) portfolio company Embera NeuroTherapeutics has announced completion of its Series B...
EAP Portfolio Company Street Car Snoballs Announces Franchising of Business

EAP Portfolio Company Cotton St. Farms earns Shreveport Business of the Week

EAP Portfolio Company Two Warriors Meadery Launches First Meadery in Louisiana
